Doseology Sciences Receivables

The latest receivables for DOSEF is $99K as of March 2026. That compares with $29K in the prior-year period — up 243.5% year over year. Investors often review this figure alongside Doseology Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, DOSEF's receivables moved from $29K to $99K — a 243.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Doseology Sciences's operating scale or balance-sheet position.

A receivables figure of $99K for DOSEF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DOSEF's receivables ($99K), review year-over-year change from $29K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.